Biological drugs market global industry analysis, size, share, growth, trends and forecast, 2014 - 2020

  • Published on

  • View

  • Download

Embed Size (px)


Biological drugs are typically derived from living cells and are used in the treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders. Biological drugs include therapeutic proteins, monoclonal antibody (mAb) and vaccines. The biological drugs market is growing due to the increasing prevalence of chronic diseases and the demand for biological drugs is growing due to the increase in the global geriatric population. Moreover, various government associations are also supporting in growth of biological drugs market. Furthermore, advancement in biomedical sciences holds immense potential for the growth of the biologic drugs market.


<p>Transparency MarketResearch</p> <p>Biological Drugs Market - GlobalIndustry Analysis, Size, Share,Growth, Trends and Forecast,</p> <p>2014 - 2020</p> <p>Single User License:USD 4795Multi User License:USD 7795Corporate User License: USD 10795</p> <p>Global Biological Drugs Market is Expected to Reach USD287,139.7 Million in 2020: Transparency Market Research</p> <p>Transparency Market Research State Tower,</p> <p>90, State Street, Suite 700.Albany, NY 12207United</p> <p>145 Page ReportPublished Date01-July-2014</p> <p>Buy Now Request Sample</p> <p>Press Release</p> <p>Biological Drugs Market</p> <p>Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2014 - 2020</p> <p>According to a new market report published by Transparency Market Research "Biological Drugs Market -Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020," the global biologicaldrugs market is estimated at USD 161,056.5 million in 2014 and is expected to grow at a CAGR of 10.1%from 2014 to 2020, to reach an estimated value of USD 287,139.7 million in 2020.</p> <p>Browse the full Biological Drugs Market Report at</p> <p></p> <p>The biological drugs market is witnessing a significant growth due to the increasing prevalence of chronicdiseases and increase in the global geriatric population. Biological drugs are used in treatment andprevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and othermedical disorders. Moreover, various government associations are also promoting the usage of biologicaldrugs. Furthermore, advancement in biomedical sciences holds immense potential for the growth of thebiologic drugs market.</p> <p>On the other hand, high cost of biological drugs and patent expiry of blockbuster drugs impede the growthof the market. Moreover, the risk of adverse effects associated with biologic injectable drugs is also one ofthe key restraints of the market. As a result, biological drugs market is expected to grow a CAGR of about10.1% during 2014-2020.</p> <p>North America is the largest market for biological drugs. Increased use of biological drugs for the treatmentof diseases such as cancer, diabetes and other chronic diseases are supporting the growth of the biologicaldrugs market in the region. The American Center for Biological Medicine (ACBM) is one of the largestbiological medicine clinics in the U.S. </p> <p>Similarly, the European biological drugs market is growing rapidly due to increased usage of biologicaldrugs for the treatment of various chronic diseases such as diabetes, cancer and inflammatory diseases.</p> <p>In Asia, low manufacturing cost is attracting many biological manufactures to invest in Asian countries,supporting the growth of the biological drugs market. Moreover, Asian governments are also supporting</p> <p>Transparency Market Research2</p> <p>REPORT DESCRIPTION</p> <p>Biological Drugs Market</p> <p>growth of the biological drugs market by increased investment on biotech companies for construction ofR&amp;D and manufacturing facilities.</p> <p>Request Sample Report From here : </p> <p>;rep_id=1694</p> <p>Novartis AG, Pfizer Inc., GlaxoSmithKline plc. and Merck &amp; Co., Inc. are the some of the leading players inthe global biological drugs market. Other major players of biological drugs market include AbbottLaboratories, Biogen Idec and Amgen Inc.</p> <p>The global market of biological drugs is segmented as follows:</p> <p>Biological Drugs Market, By Therapeutic Protein </p> <p> Enbrel</p> <p> Lantus</p> <p> Neulasta</p> <p> Avonex</p> <p> NovoLog</p> <p> Rebif</p> <p> Humalog</p> <p> Aranesp</p> <p> Epogen</p> <p> Levemir</p> <p> Victoza</p> <p> Betaseron</p> <p>Transparency Market Research3</p> <p>Biological Drugs Market</p> <p> Neupogen</p> <p> Eylea</p> <p>Biological Drugs Market, By Monoclonal Antibody (mAb) </p> <p> Humira</p> <p> Remicade</p> <p> Rituxan</p> <p> Avastin</p> <p> Herceptin</p> <p> Lucentis</p> <p>Biological Drugs Market, By Vaccine </p> <p> Prenvar 13</p> <p> Gardasil</p> <p> Fluzone</p> <p> Varivax</p> <p> Cervarix</p> <p>Biological Drugs Market, by Geography </p> <p> North America</p> <p> Europe</p> <p> Asia</p> <p> Rest of the World (RoW)</p> <p>Transparency Market Research4</p> <p>Biological Drugs Market</p> <p>Browse All Pharmaceutical Market Research Reports @</p> <p></p> <p>Chapter 1 Preface</p> <p>1.1 Report Description</p> <p>1.2 Research methodology </p> <p> 1.2.1 Sources </p> <p> Secondary Research </p> <p> Primary Research</p> <p> Assumptions</p> <p>Chapter 2 Executive Summary </p> <p>Chapter 3 Global Biological Drugs Market Industry Analysis </p> <p>3.1 Introduction </p> <p>3.2 Market Drivers</p> <p> 3.2.1 Increasing prevalence of chronic diseases enhance the market growth </p> <p> 3.2.2 Globally geriatric population increases the demand of biological drugs </p> <p> 3.2.3 Various government associations are promoting usage of biological drugs</p> <p>3.3 Market Opportunities</p> <p>Transparency Market Research5</p> <p>TABLE OF CONTENT</p> <p>Biological Drugs Market</p> <p> 3.3.1 Advancement in biomedical science promises to boost the development of new biological products</p> <p>3.4 Restraints </p> <p> 3.4.1 High cost of biological drugs impedes market growth</p> <p> 3.4.2 Patent expiration of various blockbuster biological drugs</p> <p> 3.4.3 Risk of adverse effects associated with biological injectable medicines</p> <p>Chapter 4 Market Trends </p> <p> 4.1.1 Increasing use of anti-Vascular Endothelial Growth Factor (VEGF) therapy is gaining popularity in biopharmaceutical industry</p> <p> 4.1.2 Genetically Modified Organisms (GMOs) are gaining importance in biological drugs market</p> <p>Related &amp; Recently Published Reports by Transparency Market Research </p> <p>Drugs of Abuse Testing Market: </p> <p></p> <p>Ophthalmic Drugs Market: </p> <p></p> <p>Chapter 5 Porters Five Forces Analysis </p> <p> 5.1.1 Bargaining power of suppliers </p> <p> 5.1.2 Bargaining power of buyers </p> <p> 5.1.3 Threat of new entrants </p> <p>Transparency Market Research6</p> <p>Biological Drugs Market</p> <p> 5.1.4 Threat of substitutes </p> <p> 5.1.5 Degree of competition </p> <p>Chapter 6 Global Market Size and Forecast </p> <p>Chapter 7 Segment Analysis, by Therapeutic Protein </p> <p>7.1 Enbrel </p> <p>7.2 Lantus </p> <p>7.3 Neulasta </p> <p>7.4 Avonex </p> <p>7.5 NovoLog </p> <p>7.6 Rebif </p> <p>7.7 Humalog </p> <p>7.8 Aranesp </p> <p>7.9 Epogen</p> <p>7.10 Levemir </p> <p>7.11 Victoza </p> <p>7.12 Betaseron</p> <p>7.13 Neupogen</p> <p>7.14 Eylea</p> <p>Transparency Market Research7</p> <p>Biological Drugs Market</p> <p>Chapter 8 Segment Analysis, by mAb </p> <p>8.1 Humira </p> <p>8.2 Remicade </p> <p>8.3 Rituxan </p> <p>8.4 Avastin </p> <p>8.5 Herceptin </p> <p>8.6 Lucentis </p> <p>Browse the full Biological Drugs Market Report at</p> <p></p> <p>Chapter 9 Segment Analysis, by Vaccine </p> <p>9.1 Prenvar 13 </p> <p>9.2 Gardasil</p> <p>9.3 Fluzone</p> <p>9.4 Varivax </p> <p>9.5 Cervarix </p> <p>Chapter 10 Regional Analysis</p> <p>10.1 Scenario in North America</p> <p>10.2 Scenario in Europe </p> <p>Transparency Market Research8</p> <p>Biological Drugs Market</p> <p>10.3 Scenario in Asia </p> <p>10.4 Rest of the World (RoW) </p> <p>Chapter 11 Pipeline Biologic Drugs </p> <p>11.1 Biological drugs under development for auto-immune diseases </p> <p>11.2 Biological drugs under development for blood diseases </p> <p>11.3 Biological drugs under development for cancer and related conditions </p> <p>11.4 Biological drugs under development for diabetes and cardiovascular diseases </p> <p>Chapter 12 Competitive Landscape</p> <p>Chapter 13 Company Profiles </p> <p>13.1 Pfizer Inc. </p> <p> 13.1.1 Company Overview </p> <p> 13.1.2 Product &amp; Segments </p> <p> 13.1.3 Financial Performance </p> <p> 13.1.4 Strategic Developments </p> <p>13.2 Abbott Laboratories</p> <p> 13.2.1 Company Overview</p> <p> 13.2.2 Product &amp; Segments </p> <p> 13.2.3 Financial Performance </p> <p>Transparency Market Research9</p> <p>Biological Drugs Market</p> <p> 13.2.4 Strategic Developments </p> <p>13.3 Novartis AG </p> <p> 13.3.1 Company Overview </p> <p> 13.3.2 Product &amp; Segments </p> <p> 13.3.3 Financial Performance </p> <p> 13.3.4 Strategic Developments </p> <p>13.4 Eli Lilly and Company </p> <p> 13.4.1 Company Overview </p> <p> 13.4.2 Product &amp; Segments </p> <p> 13.4.3 Financial Performance</p> <p> 13.4.4 Strategic Developments</p> <p>13.5 GlaxoSmithKline plc.</p> <p> 13.5.1 Company Overview</p> <p> 13.5.2 Product &amp; Segments</p> <p> 13.5.3 Financial Performance </p> <p> 13.5.4 Strategic Developments </p> <p>13.6 Bristol-Myers Squibb Company </p> <p> 13.6.1 Company Overview </p> <p> 13.6.2 Product &amp; Segments </p> <p> 13.6.3 Financial Performance </p> <p> 13.6.4 Strategic Developments </p> <p>13.7 Merck &amp; Co., Inc. </p> <p>Transparency Market Research10</p> <p>Biological Drugs Market</p> <p> 13.7.1 Company Overview </p> <p> 13.7.2 Product &amp; Segments </p> <p> 13.7.3 Financial Performance </p> <p> 13.7.4 Strategic Developments </p> <p>13.8 Amgen Inc. </p> <p> 13.8.1 Company Overview </p> <p> 13.8.2 Product &amp; Segments </p> <p> 13.8.3 Financial Performance </p> <p> 13.8.4 Strategic Developments </p> <p>13.9 Baxter International Inc. </p> <p> 13.9.1 Company Overview </p> <p> 13.9.2 Product &amp; Segments </p> <p> 13.9.3 Financial Performance </p> <p> 13.9.4 Strategic Developments </p> <p>13.10 Biogen Idec </p> <p> 13.10.1 Company Overview </p> <p> 13.10.2 Product &amp; Segments </p> <p> 13.10.3 Financial Performance </p> <p> 13.10.4 Strategic Developments </p> <p>Browse the full Biological Drugs Market Report at</p> <p></p> <p>Transparency Market Research11</p> <p>Biological Drugs Market</p> <p>Transparency Market Research is a market intelligence company providing global business informationreports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.</p> <p>We are privileged with highly experienced team of Analysts, Researchers and Consultants, who useproprietary data sources and various tools and techniques to gather, and analyze information. Ourbusiness offerings represent the latest and the most reliable information indispensable for businesses tosustain a competitive edge.</p> <p>Contact:</p> <p>Transparency Market Research90 State Street, Suite 700, AlbanyNY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-552-3453Email: sales@transparencymarketresearch.comWebsite: </p> <p>Transparency Market Research12</p> <p>About Us</p>


View more >